Astha Bhatia - Concepedia

Author

Astha Bhatia

Université Paris-Saclay ORCID

Also Known As

Astha Bhatia, Bhatia, Astha

Publications

421

Citations

H-Index

Concepts

All Affiliations

Université Paris-Saclay Cornell University Rocky Mountain Cancer Centers Guru Nanak Dev University Vanderbilt University

About

Astha Bhatia is an author at Université Paris-Saclay specializing in medicine, radiation oncology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	100
2	Health Sciences	2	2	55
3	Biochemistry	2	2	45
4	Engineering	1	1	29
5	Natural Sciences	1	1	16

Astha Bhatia

Publications

318

Citations

H-Index

Page 1

	Year	Citations
In vitro evaluation of the α-glucosidase inhibitory potential of methanolic extracts of traditionally used antidiabetic plants Astha Bhatia, Balbir Singh, Rohit Arora, BMC Complementary and Alternative Medicine	2019	154
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3 Petros Grivas, Damien Pouessel, Chandler H. Park, Journal of Clinical Oncology	2024	64
TROPHY-U-01 Cohort 3: Sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) who progressed after platinum (PLT)-based regimens. Petros Grivas, Damien Pouessel, Chandler H. Park, Journal of Clinical Oncology Cancer ManagementImmunologyImmunotherapeuticsImmunotherapyMetastatic Urothelial Cancer	2022	35
Plant-Based Polysaccharides and their Health Functions Saroj Arora, Davinder Singh, Ankita Rajput, Functional Foods in Health and Disease Food FunctionBiomanufacturingEngineeringMixed BiopolymersBiochemistry	2021	29
Primary analysis of TROPHY-U-01 cohort 3, a phase 2 study of sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) that progressed after platinum (PT)-based therapy. Petros Grivas, Damien Pouessel, Chandler H. Park, Journal of Clinical Oncology ImmunologyPharmacotherapyImmunotherapeuticsImmunotherapyPre-clinical Pharmacology	2023	20
Di-2-pyridylketone-N1-substituted thiosemicarbazone derivatives of copper(II): Biosafe antimicrobial potential and high anticancer activity against immortalized L6 rat skeletal muscle cells Tarlok S. Lobana, Mani Kaushal, Ritu Bala, Journal of Inorganic Biochemistry Medicinal ChemistryBiosafe Antimicrobial PotentialBiochemistryMedicineNatural Sciences	2020	16

Page 1